PHNOM PENH, CAMBODIA, 08 June 2018 - JOINT PRESS RELEASE - Cambodia has achieved a landmark public health victory by reducing the prevalence of hepatitis B surface antigen among children to less than 1 percent. Cambodia joins 20 of 37 other countries and areas in the WHO Western Pacific Region that have been verified by an independent panel as having met this goal by 2017.
Vietnam boosts hepatitis B vaccination for newborns in remote areas
June 20, 2018 - In the first three months of 2018, vaccination coverage was expanded on schedule. The rate of babies getting hepatitis B shots within 24 hours of birth reached 16.9 percent, compared to 16.2 percent in the same period of 2017.
In May 2012, the World Health Assembly endorsed the Global Vaccine Action Plan 2011–2020 which restates existing immunization goals and sets new goals for the Decade through six strategic objectives and actions required to achieve the goals.
Viral hepatitis is an inflammation of the liver caused by one of the five hepatitis viruses: A, B, C, D and E. The five hepatitis viruses are transmitted through different routes: hepatitis A and E through contaminated food and water; hepatitis B through blood and other bodily fluids; hepatitis C and D mostly through blood. These viruses can all cause acute hepatitis. Most people fully recover from acute infection. However, hepatitis B and C infection can lead to chronic liver disease, which is the most common cause of liver cirrhosis and liver cancer. Each year, 1.4 million people die from the various forms of viral hepatitis worldwide.
- Delivering additional interventions to eliminate mother-to-child transmission of hepatitis B in the Western Pacific
- Commonwealth of the Northern Mariana Islands achieves hepatitis B milestone
- Tenofovir reduces mother-to-child transmission of hepatitis B: new study
- Getting the right hepatitis medication at the right price
- Hepatitis B in Kiribati: an island epidemic
- Hepatitis: a crisis in Mongolia